- Home
- E vs ALC Comparison
E vs ALC Comparison
Compare E & ALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- E
- ALC
- Stock Information
- Founded
- E 1953
- ALC 1945
- Country
- E Italy
- ALC Switzerland
- Employees
- E N/A
- ALC N/A
- Industry
- E Oil & Gas Production
- ALC Ophthalmic Goods
- Sector
- E Energy
- ALC Health Care
- Exchange
- E Nasdaq
- ALC Nasdaq
- Market Cap
- E 49.2B
- ALC 43.4B
- IPO Year
- E 1995
- ALC N/A
- Fundamental
- Price
- E $33.15
- ALC $87.32
- Analyst Decision
- E Buy
- ALC Buy
- Analyst Count
- E 4
- ALC 10
- Target Price
- E $31.60
- ALC $107.00
- AVG Volume (30 Days)
- E 323.8K
- ALC 1.5M
- Earning Date
- E 07-25-2025
- ALC 08-19-2025
- Dividend Yield
- E 4.52%
- ALC 0.25%
- EPS Growth
- E N/A
- ALC 6.66
- EPS
- E 0.83
- ALC 2.25
- Revenue
- E $98,314,958,896.00
- ALC $9,925,000,000.00
- Revenue This Year
- E N/A
- ALC $6.22
- Revenue Next Year
- E $2.45
- ALC $7.16
- P/E Ratio
- E $19.21
- ALC $38.72
- Revenue Growth
- E 0.42
- ALC 3.80
- 52 Week Low
- E $24.65
- ALC $80.48
- 52 Week High
- E $33.56
- ALC $101.10
- Technical
- Relative Strength Index (RSI)
- E 61.71
- ALC 48.37
- Support Level
- E $33.17
- ALC $86.01
- Resistance Level
- E $33.56
- ALC $89.46
- Average True Range (ATR)
- E 0.33
- ALC 1.23
- MACD
- E -0.03
- ALC 0.12
- Stochastic Oscillator
- E 75.88
- ALC 46.08
About E ENI S.p.A.
Eni is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2023, the company produced 0.8 million barrels of liquids and 4.6 billion cubic feet of natural gas per day. At end-2023, Eni held reserves of 6.4 billion barrels of oil equivalent, 48% of which are liquids. The Italian government owns a 30.1% stake in the company. Eni is placing its renewable and low-carbon business in a separate entity called Plentitude, which it will likely list publicly at some point.
About ALC Alcon Inc.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.